Catatonia was first described in 1874 and can be caused by neurological or psychiatric conditions. Common features include immobility, stupor, negativism, and waxy flexibility. Lorazepam is the first-line treatment, while electroconvulsive therapy can provide definitive treatment for severe cases. Catatonia is increasingly recognized in pediatric populations comorbid with autism or other developmental disorders. Prompt diagnosis and treatment with benzodiazepines or ECT is important.